What is the KALV stock price prediction for next 2 weeks?

According to our price prediction algorithm,KalVista Pharmaceuticals, Inc. (KALV) price will be around $15.39 in the next 2 weeks. This means it will increase by 0.5114304376224604 from the last closing price. This prediction may vary from other time period filters for KALV stock.

What can be the highest Possible price of KALV stock in next 2 weeks?

Our forecast algorithm expects that in 2 weeks, KALV can achieve the highest price of $16.44 which is 7.366606477875012 higher than last closing price. This prediction may vary from other time period filters for KALV stock.

What can be the lowest Possible price of KALV stock in next 2 weeks?

As per the forecast and algorithmic analysis, KALV stock price can be as low as $14.33 which is -6.3928375546331475 lower than the current price in the next 2 weeks. This prediction may vary from other time period filters for KALV stock.

Will KALV stock go high in the next 2 weeks?

Yes, our stock forecasting algorithm shows that KALV stock will gain0.5114304376224604 in the next 2 weeks. This prediction may vary from other time period filters for KALV stock.

What is KALV stock last closing price?

Last closing price of KALV stock was $15.31.

What is KALV stock price prediction?

KALV stock price prediction means predicting the future closing prices of KALV stock based on its past data. Our forecasting algorithm uses various machine learning and deep learning techniques to forecast the future behavior of KALV stock in a certain time period.

How we predict KALV stock future prices?

If you are searching for KALV stock forecast, analysis or price prediction, then you might be wondering what KalVista Pharmaceuticals, Inc. (KALV) will do in the future. Our KALV price predictions are based on various Machine Learning based algorithms with an aim to try and predict future price movements. This KALV price prediction will likely answer most of your questions.

How frequent we update KALV stock predictions?

We are updating the forecasts for the KALV stock on daily basis.

Is using ML forecasting for KALV stock a good way?

Yes. Stock Price Prediction is one of the most exciting applications of Machine Learning. By leveraging data from the past, it is possible to use forecasting models to make accurate predictions about future stock prices. This can be incredibly beneficial for investors and traders, as it gives them the ability to make more informed decisions about when to buy and sell. Investing in the stock market can be a risky endeavor, but leveraging Machine Learning can make it a bit less daunting and more profitable.

Is the Prediction for KALV stock same for all the time periods?

No, the prediction for KALV stock is not same for all time periods. The forecasts may vary depending on the differences in the time period.

KalVista Pharmaceuticals, Inc. Stock Forecast and Stock Price Prediction

Stock Forecast Chart

Stock Price Prediction Summary

Closed Price$15.31-6.3%Since 2 Weeks

Predicted Price$15.390.51%For 2 Weeks

Upper Predicted Price$16.447.37%For 2 Weeks

Lower Predicted Price$14.33-6.39%For 2 Weeks

Forecast Score Based on 2 Weeks

Based on our forecast, the price of KALV will rise by +0.51% over the next 2 Weeks and hit $15.39 by Tuesday, February 3, 2026. In that time frame, KALV's share price is expected to range between $14.33 and $16.44.

BearishAverageBullish

Date	Predicted Lower	Predicted	Predicted Upper
Feb 3, 2026	14.33	15.39	16.44
Feb 2, 2026	14.78	15.82	16.97
Jan 30, 2026	14.51	15.62	16.64
Jan 29, 2026	14.87	15.99	17.16
Jan 28, 2026	14.37	15.49	16.61
Jan 27, 2026	14.33	15.35	16.46
Jan 26, 2026	14.68	15.79	16.98
Jan 23, 2026	14.46	15.58	16.74
Jan 22, 2026	14.82	15.95	17.10
Jan 21, 2026	14.40	15.45	16.57

KALV shares rose +3.04% in Wednesday, January 21, 2026's trading session, rising from a previous close of $15.31 to move at $15.78. The stock demonstrated notable intraday movement (see KALV's key stats for a full breakdown), fluctuating between $15.24 and $15.85, a +4.00% trading range. While recent weeks have seen some volatility, KALV has managed to secure a +0.16% gain over the past 2 weeks. The upward price movement was accompanied by increased trading volume, with approximately 1.26M shares changing hands, 187.78K more than the previous session. This amounted to $19.80M in total market activity.

Will KALV Continue Its Upward Trend?

According to analyst ratings and projections for KALV, KalVista Pharmaceuticals, Inc. shares are anticipated to increase by +4.03%, potentially reaching $16.44 per share by February 3, 2026. Short-term technical indicators currently suggest a neutral sentiment for KALV. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 17 positive trading days within the past 30 sessions. Based on the KALV stock forecast, now is a good time to buy KALV stock because its current trading price is +2.51% above our predicted value, hinting at a possible undervaluation. For deeper insights, view our sentiment analysis on KALV covering social and institutional perspectives.

KALV Technical Momentum: Overbought, Oversold, or Neutral?

An analysis of Relative Strength Index (RSI) indicators provides insight into KALV's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 53.31% to 53.78%) suggest the stock is in a neutral to slightly bearish momentum phase. The 50-day RSI, at 53.98%, suggests a neutral medium-term outlook. Additionally, the 100-day RSI, at 53.18%, maintains a neutral outlook for the long term. Insights into KALV's shareholder base show how institutional investors are positioning themselves during these momentum shifts

KalVista Pharmaceuticals Short-Term Forecasts

KALV Forecast For Next 5 Days

Our algorithm anticipates KalVista Pharmaceuticals (KALV) stock could hit $14.67 by Jan 28, 2026. This represents a -7.03% fall from today's price, following a -6.59% change over the past five days.

KALV Forecast For Next 30 Days

Based on analysis of market trends, the outlook for KalVista Pharmaceuticals, Inc. (KALV) stock over the next 30 days is largely negative. Price forecasts suggest an average target of $15.52, which would mean a -1.62% decrease from the current price of $15.78. Projections for this period range from a high of $18.18 to a low of $13.41.

KALV Forecast For Next 90 Days

Our proprietary market analysis suggests predictions for KalVista Pharmaceuticals's price over the next three months point to a rise. KALV stock is expected to peak at $44.02 on Feb 16, 2026 before potentially dipping to $29.69 on Apr 07, 2026. On average, KALV is likely to trade around $36.69 in the coming 90 days.

KalVista Pharmaceuticals Stock Forecast 2025

Based on our predictive models, KalVista Pharmaceuticals (KALV) is expected to trade between $23.62 and $47.07 throughout 2026. This would result in an average price of $33.53, potentially offering investors a +112.55% return from current levels.

KalVista Pharmaceuticals, Inc. Monthly Forecast 2026–2027

January 2026

According to our latest forecast models, KalVista Pharmaceuticals, Inc. (KALV) is positioned to show a strong performance in January 2026. The price is predicted to move between $33.65 and $41.19, settling at an average of $37.44. This could translate to a +137.34% gain.

February 2026

Based on current market signals, KalVista Pharmaceuticals, Inc. is projected to trend february 2026. We forecast a trading range from $39.86 to $44.02, with a likely average price of $42.85. Investors could expect a potential return of +171.63%.

March 2026

Our predictive algorithms indicate KalVista Pharmaceuticals, Inc. stock may see a shift in March 2026. The expected range spans $30.22–$39.11, with an average target of $34.22. This represents a positive outlook and a possible gain of +116.93%.

April 2026

Analyzing established trends, KalVista Pharmaceuticals, Inc. looks set to move in April 2026. Projections place the stock between $29.69 and $37.12, averaging around $32.67. This suggests a +107.10% gain from current levels.

May 2026

Market indicators suggest KalVista Pharmaceuticals, Inc. could experience notable changes during May 2026. Prices could fluctuate within $31.14 to $38.88, with a midpoint forecast of $33.87. The stock might deliver a +114.71% gain.

June 2026

Forecasting for June 2026, models estimate that KalVista Pharmaceuticals, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $31.62 and $36.42, averaging $32.44. This signals a positive trajectory with potential returns around +105.64%.

July 2026

According to our latest forecast models, KalVista Pharmaceuticals, Inc. (KALV) is positioned to show a strong performance in July 2026. The price is predicted to move between $35.12 and $47.07, settling at an average of $39.62. This could translate to a +151.16% gain.

August 2026

Based on current market signals, KalVista Pharmaceuticals, Inc. is projected to trend august 2026. We forecast a trading range from $29.92 to $37.90, with a likely average price of $31.36. Investors could expect a potential return of +98.80%.

September 2026

Our predictive algorithms indicate KalVista Pharmaceuticals, Inc. stock may see a shift in September 2026. The expected range spans $28.62–$35.81, with an average target of $30.33. This represents a positive outlook and a possible gain of +92.27%.

October 2026

Analyzing established trends, KalVista Pharmaceuticals, Inc. looks set to move in October 2026. Projections place the stock between $23.62 and $33.16, averaging around $25.74. This suggests a +63.17% gain from current levels.

November 2026

Market indicators suggest KalVista Pharmaceuticals, Inc. could experience notable changes during November 2026. Prices could fluctuate within $24.24 to $39.26, with a midpoint forecast of $27.56. The stock might deliver a +74.71% gain.

December 2026

Forecasting for December 2026, models estimate that KalVista Pharmaceuticals, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $36.09 and $45.66, averaging $36.66. This signals a positive trajectory with potential returns around +132.39%.

January 2027

According to our latest forecast models, KalVista Pharmaceuticals, Inc. (KALV) is positioned to show a strong performance in January 2027. The price is predicted to move between $35.69 and $41.64, settling at an average of $34.26. This could translate to a +117.18% gain.

KALV's history of dividends and stock splits also plays a role in long-term investor confidence.